Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case-control study
- PMID: 38008767
- PMCID: PMC10680232
- DOI: 10.1186/s41021-023-00289-y
Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case-control study
Abstract
Background: Non-Small Cell Lung Cancer displays several genetic mutations including epidermal growth factor receptor. This study's objective was to determine if the EGFR exon19 rs121913438 and exon21 rs121434568 variations play a role in NSCLC susceptibility.
Methods: Case-control research was done at the Mansoura university oncology center including 124 NSCLC patients, and 124 healthy volunteers. blood was used to obtain genomic DNA. ARMS-PCR was used to genotype single-nucleotide polymorphisms.
Results: Molecular study for EGFR exon 19 del. showed NSCLC cases were significantly associated with a higher proportion of heterozygous WD, WD + DD dominant genotypes, and mutant D allele, (p < 0.05 for each), with a risk to develop NSCLC. also, NSCLC cases were significantly associated with a higher proportion of heterozygous TG, TG + GG dominant genotype, G mutant allele, (p < 0.05 for each), with a risk to develop LC (OR > 1 for each). regarding the two EGFR mutations, TTF1 staining was significantly associated with WD + DD genotypes for EGFR exon 19 del But not EGFR exon 21. No substantial differences were found among all studied cases with CK7 or napsin A Tumor cytochemistry.
Conclusions: The WD heterozygous genotype and D allele in exon 19 del. mutation as well as the TG heterozygous and G allele in exon 21 substitution mutation in EGFR gene are strongly associated with the development of advanced-NSCLC in the Egyptians.
Keywords: EGFR gene; Genetic mutation; Lung carcinoma.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
The role of epidermal growth factor receptor (EGFR) common gene mutations in Iranian women with uterine fibroids.Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:103-107. doi: 10.1016/j.ejogrb.2018.08.017. Epub 2018 Aug 16. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 30149365
-
High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer.Mod Pathol. 2014 Dec;27(12):1590-8. doi: 10.1038/modpathol.2014.67. Epub 2014 Apr 25. Mod Pathol. 2014. PMID: 24762545
-
Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.J Cancer Res Clin Oncol. 2022 Feb;148(2):321-330. doi: 10.1007/s00432-021-03818-w. Epub 2021 Oct 24. J Cancer Res Clin Oncol. 2022. PMID: 34693477 Free PMC article.
-
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).Lung Cancer. 2019 Nov;137:113-122. doi: 10.1016/j.lungcan.2019.09.017. Epub 2019 Sep 23. Lung Cancer. 2019. PMID: 31568888 Free PMC article. Review.
-
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer.BMJ Open Respir Res. 2023 Jun;10(1):e001492. doi: 10.1136/bmjresp-2022-001492. BMJ Open Respir Res. 2023. PMID: 37321664 Free PMC article. Review.
References
-
- Ferlay. J, Colombet. M, Soerjomataram. I, Donald M. Parkin, Piñeros. M, Znao. A. Cancer statistics for the year 2020: An overview, Int. J. Cancer 2021, 10.1002/ijc.33588. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous